Lisinopril

Analyzing over US$ 90 billion of Medicare Prescription Drug (Part D) Spending in 2016

This week, PharmaCompass reviews the recently released data on prescription drugs paid for under th

Dead fish in Hyderabad puts pharma majors under scrutiny; False data uncovered in AstraZeneca’s US$ 4 billion buy

This week, Phispers has news from across the world. While China is trying to speed up approval of dr

FDA’s 2016 Approvals of New Drugs, Formulations, Strengths & More

After 2 years of sky-high approval numbers, the US Food and Drug Administration’s (FDA) Center

Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend

In less than three weeks, Donald Trump will assume office as the President of the United States. He